Strength
30 mg/1
Manufacturer
AvPAKNDC
50268009212
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ARIPIPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA205064On Market Since
4/28/2016
Pharmacological Classes
Price Statistics
The NADAC for ARIPIPRAZOLE 30 MG TABLET has been published 450 times since Nov 15, 2017, and over the history we have for it it has declined 83.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1670 per EA |
|---|---|
| All-time high | $0.9922 (Nov 15, 2017) |
| All-time low | $0.1365 (Nov 20, 2024) |
| 52-week high | $0.1829 |
| 52-week low | $0.1670 |
| Median price | $0.2789 |
| Average price | $0.3342 |
| Largest weekly change | +41.4% (Aug 21, 2024) |
| Weeks tracked | 450 |
| Tracking since | Nov 15, 2017 |
Generic Alternatives
The matcher finds 13 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ARIPIPRAZOLE 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ARIPIPRAZOLE 30 MG TABLET, manufactured by AvPAK, is $0.1670 per EA (NDC 50268009212), effective Jun 24, 2026.
How has the price of ARIPIPRAZOLE 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for ARIPIPRAZOLE 30 MG TABLET has declined 83.2%. It has been tracked across 450 weekly CMS publications since Nov 15, 2017.
What are the highest and lowest recorded NADAC prices for ARIPIPRAZOLE 30 MG TABLET?
Since Nov 15, 2017, the NADAC for ARIPIPRAZOLE 30 MG TABLET has ranged from a low of $0.1365 (Nov 20, 2024) to a high of $0.9922 (Nov 15, 2017), with a median of $0.2789 per EA.
Are there cheaper alternatives to ARIPIPRAZOLE 30 MG TABLET?
13 NADAC-published products share the same active ingredient, strength, and dosage form as ARIPIPRAZOLE 30 MG TABLET, but none are currently priced below it.
Who manufactures ARIPIPRAZOLE 30 MG TABLET?
ARIPIPRAZOLE 30 MG TABLET (NDC 50268009212) is labeled by AvPAK, and CMS classifies it as a generic product.
Related Drugs
Same classification